Sun Pharmaceutical Industries Limited (SUNPHARMA) — share transfer

· NSE Neutral
📢 Key Event
Confirmation certificate issued for dematerialized securities
💡 Investor Takeaway
The confirmation ensures shareholding records are updated and securities remain listed on major exchanges.

Sun Pharmaceutical Industries Limited received a confirmation certificate from MUFG Intime India Private Limited, its share transfer agent, confirming dematerialized securities for the quarter ended 30 June 2026 were accepted and listed on NSE and BSE. The certificate was issued on 1 July 2026 under SEBI regulations.

📄 View Original Announcement (PDF)

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUNPHARMA — Free

Free account · 2 AI queries/day